Does paclitaxel stent coating inhibit neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis?
Paclitaxel-coated coronary stents produced a significant dose-dependent inhibition of neointimal hyperplasia and luminal encroachment in the pig LAD 28 days after implantation; later effects require further study. These results demonstrate the potential therapeutic benefit of paclitaxel-coated coronary stents in the prevention and treatment of human coronary restenosis.
Our data show that increased Hct is associated with an increased risk of dying from CVD--independent of conventional CVD risk factors.